Table 2.
Rank |
GO ID |
GO term |
p-Value |
q-Value |
---|---|---|---|---|
Cd | ||||
1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 1.0 × 10−7 | 0.002 |
2 | GO:0050851 | antigen receptor-mediated signaling pathway | 3.1 × 10−5 | 0.17 |
3 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic | 2.5 × 10−4 | 0.86 |
4 | GO:0005509 | calcium ion binding | 3.0 × 10−4 | 0.86 |
5 | GO:0002376 | immune system process | 1.2 × 10−3 | >0.9 |
6 | GO:0008142 | oxysterol binding | 1.4 × 10−3 | >0.9 |
7 | GO:0022410 | circadian sleep/wake cycle process | 1.6 × 10−3 | >0.9 |
8 | GO:2000107 | negative regulation of leukocyte apoptotic process | 1.7 × 10−3 | >0.9 |
9 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 2.5 × 10−3 | >0.9 |
10 | GO:0042053 | regulation of dopamine metabolic process | 2.5 × 10−3 | >0.9 |
Mn | ||||
1 | GO:0034641 | cellular nitrogen compound metabolic process | 1.4 × 10−6 | 0.002 |
2 | GO:0022402 | cell cycle process | 1.5 × 10−5 | 0.02 |
3 | GO:0090304 | nucleic acid metabolic process | 5.3 × 10−5 | 0.06 |
4 | GO:0006139 | nucleobase-containing compound metabolic process | 5.7 × 10−5 | 0.06 |
5 | GO:2001021 | negative regulation of response to DNA damage stimulus | 7.1 × 10−5 | 0.08 |
6 | GO:0006725 | cellular aromatic compound metabolic process | 1.1 × 10−4 | 0.1 |
7 | GO:0044237 | cellular metabolic process | 1.3 × 10−4 | 0.12 |
8 | GO:1901360 | organic cyclic compound metabolic process | 1.5 × 10−4 | 0.12 |
9 | GO:0046483 | heterocycle metabolic process | 1.5 × 10−4 | 0.12 |
10 | GO:0048534 | hematopoietic or lymphoid organ development | 2.9 × 10−4 | 0.21 |
Pb | ||||
1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules | 6.2 × 10–17 | 1.4 × 10–12 |
2 | GO:0007399 | nervous system development | 1.2 × 10−9 | 6.6 × 10−6 |
3 | GO:0022610 | biological adhesion | 3.5 × 10−8 | 10.0× 10−5 |
4 | GO:0032502 | developmental process | 9.6 × 10−8 | 2.4 × 10−4 |
5 | GO:0005509 | calcium ion binding | 1.5 × 10−5 | 0.02 |
6 | GO:0045165 | cell fate commitment | 5.6 × 10−5 | 0.07 |
7 | GO:0051410 | detoxification of nitrogen compound | 1.6 × 10−4 | 0.2 |
8 | GO:0032501 | multicellular organismal process | 1.8 × 10−4 | 0.2 |
9 | GO:0001656 | metanephros development | 1.9 × 10−4 | 0.2 |
10 | GO:0022010 | central nervous system myelination | 1.9 × 10−4 | 0.2 |
Se | ||||
1 | GO:0034062 | 5'-3' RNA polymerase activity | 1.1 × 10−4 | >0.9 |
2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity | 4.4 × 10−4 | >0.9 |
3 | GO:1905898 | positive regulation of response to endoplasmic reticulum stress | 5.2 × 10−4 | >0.9 |
4 | GO:1905214 | regulation of RNA binding | 6.5 × 10−4 | >0.9 |
5 | GO:0051276 | chromosome organization | 9.1 × 10−4 | >0.9 |
6 | GO:0001784 | phosphotyrosine residue binding | 1.2 × 10−3 | >0.9 |
7 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering | 1.3 × 10−3 | >0.9 |
8 | GO:0010836 | negative regulation of protein ADP-ribosylation | 1.8 × 10−3 | >0.9 |
9 | GO:0016233 | telomere capping | 2.1 × 10−3 | >0.9 |
10 | GO:0033044 | regulation of chromosome organization | 2.4 × 10−3 | >0.9 |
Hg | ||||
1 | GO:0009887 | animal organ morphogenesis | 2.2 × 10−7 | 0.005 |
2 | GO:0035295 | tube development | 2.6 × 10−6 | 0.03 |
3 | GO:0009888 | tissue development | 4.8 × 10−6 | 0.04 |
4 | GO:0009952 | anterior/posterior pattern specification | 1.5 × 10−5 | 0.07 |
5 | GO:0001502 | cartilage condensation | 2.8 × 10−5 | 0.09 |
6 | GO:0098743 | cell aggregation | 3.2 × 10−5 | 0.09 |
7 | GO:0007267 | cell-cell signaling | 3.7 × 10−5 | 0.09 |
8 | GO:0060541 | respiratory system development | 4.4 ×10−5 | 0.09 |
9 | GO:0003401 | axis elongation | 6.4 × 10−5 | 0.11 |
10 | GO:0007389 | pattern specification process | 8.2 × 10−5 | 0.11 |
aCovariate model adjusted for cell type principal components 1 and 2, maternal age, foetal sex, and hybridization date.